Prostate specific antigen
About the parameter
Prostate specific antigen (PSA) is a glycoprotein with a molecular weight of 34,000 which is located in the prostatic organization and seminal plasma. The PSA out of the blood increases with the occurence of prostate cancer, prostatomegaly, prostatitis and other prostatic diseases. Particularly blood PSA levels increase remarkably in patients with prostate cancer.
Antibodyadsorbed latex particles and PSA in the sample react immunologically, and causing the latex particles to agglutinate. This agglutination results in a change of turbidity, and the change in absorbance is a measure of the amount of PSA in the sample.
Serum/plasma: 0 – 50 ng/ml
EDTA whole blood: 0 – 50 ng/ml
Test takes approx. 6 minutes when using serum, and about 8 minutes when using whole blood.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser PSA assay here: Evaluation Eurolyser PSA
Please note: depending on the time of the market launch of an assay, the respective assay evaluation was carried out using either a Eurolyser smart instrument or a Eurolyser CUBE instrument.
Since the measurement method is the same in both instruments (their photometric units are identical in construction), as was proved in this comparison study, all testkit evaluations provided on this website are valid for either instrument!
ST 0280 PSA test kit (containing 32 tests)
ST 0281 PSA test kit (containing 16 tests)
ST 2800 PSA control kit (low/high)
18. August 2020
SDMA: A new veterinary assay for evaluation of chronic kidney diseases...» Read more...
17. August 2020
Phenobarbital: A next generation epilepsy monitoring assay...» Read more...
10. December 2019
Launch of bidirectional connectivity: a feature for CUBE series instruments...» Read more...
5. December 2019